Free Trial

STERIS (STE) Competitors

STERIS logo
$246.29 -4.18 (-1.67%)
Closing price 05/21/2025 03:59 PM Eastern
Extended Trading
$246.00 -0.29 (-0.12%)
As of 07:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

STE vs. BDX, EW, IDXX, RMD, DXCM, PODD, BAX, HOLX, MASI, and GMED

Should you be buying STERIS stock or one of its competitors? The main competitors of STERIS include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Masimo (MASI), and Globus Medical (GMED). These companies are all part of the "health care equipment" industry.

STERIS vs.

Becton, Dickinson and Company (NYSE:BDX) and STERIS (NYSE:STE) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, community ranking, media sentiment and dividends.

Becton, Dickinson and Company presently has a consensus price target of $231.44, suggesting a potential upside of 33.59%. STERIS has a consensus price target of $264.00, suggesting a potential upside of 7.19%. Given Becton, Dickinson and Company's higher possible upside, research analysts clearly believe Becton, Dickinson and Company is more favorable than STERIS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45
STERIS
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

87.0% of Becton, Dickinson and Company shares are held by institutional investors. Comparatively, 94.7% of STERIS shares are held by institutional investors. 0.4% of Becton, Dickinson and Company shares are held by insiders. Comparatively, 1.1% of STERIS shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Becton, Dickinson and Company received 263 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 62.09% of users gave Becton, Dickinson and Company an outperform vote while only 59.34% of users gave STERIS an outperform vote.

CompanyUnderperformOutperform
Becton, Dickinson and CompanyOutperform Votes
606
62.09%
Underperform Votes
370
37.91%
STERISOutperform Votes
343
59.34%
Underperform Votes
235
40.66%

Becton, Dickinson and Company has a beta of 0.31, suggesting that its share price is 69% less volatile than the S&P 500. Comparatively, STERIS has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.

Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 2.4%. STERIS pays an annual dividend of $2.28 per share and has a dividend yield of 0.9%. Becton, Dickinson and Company pays out 79.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. STERIS pays out 36.8% of its earnings in the form of a dividend. Becton, Dickinson and Company has raised its dividend for 53 consecutive years and STERIS has raised its dividend for 20 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Becton, Dickinson and Company has higher revenue and earnings than STERIS. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$20.87B2.38$1.71B$5.2433.06
STERIS$5.46B4.43$378.24M$6.2039.72

STERIS has a net margin of 8.66% compared to Becton, Dickinson and Company's net margin of 8.47%. Becton, Dickinson and Company's return on equity of 15.74% beat STERIS's return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company8.47% 15.74% 7.29%
STERIS 8.66%13.91%8.64%

In the previous week, Becton, Dickinson and Company had 4 more articles in the media than STERIS. MarketBeat recorded 35 mentions for Becton, Dickinson and Company and 31 mentions for STERIS. Becton, Dickinson and Company's average media sentiment score of 1.43 beat STERIS's score of 0.98 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
29 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
STERIS
14 Very Positive mention(s)
3 Positive mention(s)
9 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive

Summary

Becton, Dickinson and Company and STERIS tied by winning 10 of the 20 factors compared between the two stocks.

Get STERIS News Delivered to You Automatically

Sign up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STE vs. The Competition

MetricSTERISSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$24.20B$9.51B$5.37B$19.41B
Dividend Yield0.91%1.61%5.22%3.83%
P/E Ratio52.2920.8726.8434.23
Price / Sales4.4363.88392.3434.85
Price / Cash15.7319.6738.2517.51
Price / Book3.765.056.794.69
Net Income$378.24M$284.66M$3.23B$1.02B
7 Day Performance0.10%-0.47%1.53%-1.74%
1 Month Performance10.49%2.15%10.06%7.46%
1 Year Performance6.81%-21.59%16.72%3.96%

STERIS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STE
STERIS
4.5649 of 5 stars
$246.29
-1.7%
$264.00
+7.2%
+6.8%$24.20B$5.46B52.2916,000News Coverage
Analyst Forecast
BDX
Becton, Dickinson and Company
4.9833 of 5 stars
$175.22
+4.8%
$231.44
+32.1%
-26.2%$50.22B$20.87B29.1177,000Positive News
High Trading Volume
EW
Edwards Lifesciences
3.8862 of 5 stars
$74.65
+1.3%
$79.45
+6.4%
-15.7%$43.88B$5.52B10.7117,300Positive News
IDXX
IDEXX Laboratories
3.3927 of 5 stars
$509.53
+3.6%
$524.75
+3.0%
-3.4%$40.98B$3.93B47.7510,800Positive News
Analyst Forecast
RMD
ResMed
4.1235 of 5 stars
$247.71
+1.1%
$258.83
+4.5%
+12.5%$36.32B$5.02B29.258,160Positive News
Analyst Revision
DXCM
DexCom
4.7415 of 5 stars
$85.05
+0.4%
$98.11
+15.4%
-35.1%$33.35B$4.15B59.487,600Positive News
PODD
Insulet
4.4316 of 5 stars
$316.67
+1.9%
$303.81
-4.1%
+77.5%$22.28B$2.07B54.692,600Positive News
BAX
Baxter International
4.6524 of 5 stars
$31.88
+3.2%
$37.25
+16.8%
-11.7%$16.36B$10.77B-24.9160,000
HOLX
Hologic
4.956 of 5 stars
$58.81
+3.6%
$78.58
+33.6%
-26.5%$13.11B$4.03B18.556,940Positive News
MASI
Masimo
4.8461 of 5 stars
$163.56
+4.5%
$191.60
+17.1%
+20.0%$8.87B$2.13B112.806,200
GMED
Globus Medical
4.8894 of 5 stars
$58.98
+5.7%
$94.00
+59.4%
-10.9%$8.11B$2.51B78.642,600Buyback Announcement
High Trading Volume

Related Companies and Tools


This page (NYSE:STE) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners